B7-H3
Use
B7-H3 is a novel member of the B7 immune protein family. It activates or inhibits tumor immune responses by binding to receptors on the surface of immune cells and has regulatory effects on non-immunological functions such as tumor migration, invasion, angiogenesis, glycometabolism, and drug resistance. Its involvement in these processes suggests important biological functions in regulating the progression of malignant tumors.
Special Instructions
Not provided.
Limitations
Stated turn-around-times are for clinical use only and subject to change based on biopharma protocol requirements. Final TATs will be specified in the biopharma study contract. Test is available for use in clinical trials or research purposes only, not for standard clinical use.
Methodology
Immunoassay (IHC)
Biomarkers
B7-H3
Protein
Result Turnaround Time
2 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Fresh)
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
Fixative should be at a 20:1 fixative to tissue ratio, 10% neutral buffered formalin (NBF) for 6-72 hours (48-72 hours PREFERRED). Specimens must be fixed in 10% NBF or B plus.
Storage Instructions
Store at 15°C to 25°C. Use a refrigerated (NOT FROZEN) gel pack in the shipment to protect from extreme temperatures. Separate gel pack from specimen.
Causes for Rejection
Specimens fixed in any fixatives other than 10% NBF or B plus will be rejected.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | ≤ 72 Hours |